NeuroSense Therapeutics Ltd.
- NRSN
- NASDAQ
- Biotechnology
- Neurodegenerative Disease Drugs
- Clinical-Stage Biotech
$2.62
Today −14.80%Quote Oct 19, 2026, 07:59 PM UTC
−54.32%over the last month
Max drawdown −58.6%From 1-month high −58.5%3 months −77.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About NeuroSense Therapeutics
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
17
Market value
$85.2M
Quote Oct 19
Floor
$2.32
11.3% below price
Resistance
$2.94
12.4% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NRSNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free